Characterization of extracellular dopamine clearance in the medial prefrontal cortex: Role of monoamine uptake and monoamine oxidase inhibition

被引:94
作者
Wayment, HK
Schenk, JO
Sorg, BA [1 ]
机构
[1] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Program Neurosci, Pullman, WA 99164 USA
[2] Washington State Univ, Dept Chem, Pullman, WA 99164 USA
[3] Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA
关键词
dopamine; cocaine; dopamine transporter; medial prefrontal cortex; monoamine oxidase; rotating disk electrode voltammetry;
D O I
10.1523/JNEUROSCI.21-01-00035.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In vitro rotating disk electrode (RDE) voltammetry and in vivo microdialysis were used to characterize dopamine clearance in the rat medial prefrontal cortex (mPFC). RDE studies indicate that inhibition by cocaine, specific inhibitors of the dopamine transporter (DAT) and norepinephrine transporter (NET), and low Na+ produced a 50-70% decrease in the velocity of dopamine clearance. Addition of the monoamine (MAO) inhibitors, L-deprenyl, clorgyline, pargyline, or in vivo nialamide produced 30-50% inhibition. Combined effects of uptake inhibitors with L-deprenyl on dopamine clearance were additive (up to 99% inhibition), suggesting that at least two mechanisms may contribute to dopamine clearance. Dopamine measured extracellularly 5 min after exogenous dopamine addition to incubation mixtures revealed that most conditions of DAT/NET inhibition did not produce elevated dopamine levels above controls. Inhibition of MAO produced elevated dopamine levels only after long-term, but not short-term, incubation in vitro. Short-term incubation of L-deprenyl combined with DAT and NET uptake inhibitors increased dopamine above control levels, consistent with more than one mechanism of dopamine clearance. Local infusion of pargyline (100 or 300 muM) into the mPFC or striatum via microdialysis produced more pronounced and immediate increases in mPFC dopamine levels compared with striatum. Furthermore, dopamine elevation in the mPFC was not accompanied by a decrease in the dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, as found in the striatum. These findings may have revealed a unique mechanism of mPFC dopamine clearance and therefore contribute to the understanding of multiple behaviors that involve mPFC dopamine transmission, such as schizophrenia, drug abuse, and working memory function.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 75 条
[1]  
Batchelor M, 1998, J NEUROSCI, V18, P10304
[2]  
BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243
[3]   Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder [J].
Boix, F ;
Qiao, SW ;
Kolpus, T ;
Sagvolden, T .
BEHAVIOURAL BRAIN RESEARCH, 1998, 94 (01) :153-162
[4]  
Burke Michael J., 1995, P1053
[5]   Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine [J].
Busch, AE ;
Karbach, U ;
Miska, D ;
Gorboulev, V ;
Akhoundova, A ;
Volk, C ;
Arndt, P ;
Ulzheimer, JC ;
Sonders, MS ;
Baumann, C ;
Waldegger, S ;
Lang, F ;
Koepsell, H .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :342-352
[6]   EFFECTS OF SELECTIVE MONOAMINE-OXIDASE INHIBITORS ON THE INVIVO RELEASE AND METABOLISM OF DOPAMINE IN THE RAT STRIATUM [J].
BUTCHER, SP ;
FAIRBROTHER, IS ;
KELLY, JS ;
ARBUTHNOTT, GW .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (03) :981-988
[7]  
Cai JX, 1997, J PHARMACOL EXP THER, V283, P183
[8]   DIRECT IN-VIVO EVIDENCE THAT D2 DOPAMINE-RECEPTORS CAN MODULATE DOPAMINE UPTAKE [J].
CASS, WA ;
GERHARDT, GA .
NEUROSCIENCE LETTERS, 1994, 176 (02) :259-263
[9]  
CASS WA, 1995, J NEUROCHEM, V65, P201
[10]  
Cesura A M, 1992, Prog Drug Res, V38, P171